(Press-News.org) Contact: Michael S. Irwig
mirwig@mfa.gwu.edu
202-741-2489
The George Washington University
Contact: Chuck Zorumski
zorumskc@psychiatry.wustl.edu
314-286-1700
Washington University School of Medicine
Alcoholism: Clinical & Experimental Research
Finasteride, medication for male pattern hair loss, may also decrease drinking
Finasteride is a synthetic drug for the treatment of male pattern hair loss and an enlarged prostate.
Rodent research has shown that finasteride can reduce alcohol intake.
A preliminary study of men with finasteride-related sexual side effects indicates that finasteride may decrease drinking.
Finasteride is a synthetic drug for the treatment of male pattern hair loss (MPHL) and an enlarged prostate. The side effects of finasteride for treatment of these two conditions can include increased rates of sexual dysfunction, such as low libido and erectile dysfunction; in fact, some men who have discontinued the medication continue to experience persistent sexual side effects. Building on the discovery that finasteride has also been shown to reduce alcohol intake and suppress alcohol preference in mice, a new study has found that a majority of men with finasteride-related sexual side effects noticed a decrease in their alcohol consumption.
Results will be published in the November 2013 issue of Alcoholism: Clinical & Experimental Research and are currently available at Early View.
"Finasteride is a synthetic medication used to treat enlarged prostates in older men," explained Michael S. Irwig, assistant professor of medicine at The George Washington University and sole author of the study. "It is also used by younger men for male pattern baldness. In younger men with male pattern baldness, [less than] five percent have developed sexual side effects. Finasteride has not been used for alcohol reduction in humans; our study is among the first to look at its effects on drinking in humans."
"Finasteride is a 5α-reductase inhibitor that blocks the production of a variety of cholesterol-derived hormones and modulators, including certain androgens and other steroids that are active in both the body and brain," explained Chuck Zorumski, the Samuel B. Guze Professor and head of psychiatry at Washington University School of Medicine. "Neuroactive steroids like allopregnanolone help to regulate brain networks involved in emotion, motivation, and cognition. There is considerable interest in whether these neurosteroids contribute to psychiatric illnesses. Alcohol is known to augment the production of neurosteroids like allopregnanolone in animals, and these steroids are thought to contribute to the sedating, intoxicating, and adverse effects of alcohol, including acute memory impairment. The present study is important because it is the first study in humans to link clinical finasteride use to changes in alcohol consumption."
Study participants were 83 otherwise healthy men who developed persistent sexual side effects associated with the use of finasteride, despite having ceased taking the medication for at least three months. Irwig used standardized interviews to collect information regarding the participants' medical histories, sexual function, and alcohol-consumption habits before and after their use of finasteride.
"While studying the persistent sexual side effects associated with finasteride, we observed that the majority of the men had reduced their alcohol consumption," said Irwig. "Many of these men completely stopped drinking alcohol, as drinking would affect them differently than before taking finasteride." More specifically, of the 63 men with persistent sexual side effects who drank at least one drink per week before using finasteride, 41 or 65 percent noticed a decrease in their drinking.
"This paper presents intriguing results that have the potential to open up an important area of clinical research," said Zorumski. "For several years, Dr. Irwig has been following a cohort of younger adult men in good general health who developed persistent sexual side effects following treatment with finasteride for MPHL. As reported previously, a significant number of these men developed psychiatric symptoms, including depression and suicidal ideation. Importantly, the psychiatric symptoms appear to have occurred following treatment with finasteride and, in this highly selected group, lasted for an extended period following discontinuation of finasteride. The present study reported significantly diminished alcohol consumption following finasteride – with 18 of the 63 men becoming abstinent. The men reported that they had more problems tolerating alcohol following finasteride treatment, including increased anxiety, tiredness, dizziness, intoxication with fewer drinks, and less euphoria."
Due to his study's preliminary nature, Irwig cautioned against rushing to prescribe finasteride for the reduction of drinking. "It is unknown whether finasteride could suppress drinking in otherwise healthy men," he said. "I hope that this study will generate more research on the effects of finasteride in humans as it relates to alcohol."
Zorumski agreed: "The men studied reflect a highly selected cohort that was treated with finasteride and developed what appear to be persistent side effects," he said. "Thus, they may not represent the broader population of individuals who are treated with finasteride. How frequently persistent side effects occur in the broader population treated with finasteride is not certain but is worth considering in future prospective studies. The importance of Dr. Irwig's preliminary study is that it should draw major attention to an important area needing further investigation."
"This study shows the importance of neurosteroids – hormones in the brain – as they relate to drinking patterns in humans," said Irwig.
"Until more systematic studies are done, clinicians should be alert to problems and side effects associated with the use of alcohol in patients treated with finasteride," added Zorumski. "The findings should spur further studies both in humans and animals to determine the role of neurosteroids in a variety of neuropsychiatric disorders, including alcoholism, depression, and anxiety. For example, it will be important to examine whether finasteride enhances the toxicity of ethanol. However, results from Dr. Irwig's cohort and previous animal studies raise intriguing possibilities about developing finasteride-type drugs for the treatment of alcohol abuse."
###
Alcoholism: Clinical & Experimental Research (ACER) is the official journal of the Research Society on Alcoholism and the International Society for Biomedical Research on Alcoholism. This release is supported by the Addiction Technology Transfer Center Network at http://www.ATTCnetwork.org.
Finasteride, medication for male pattern hair loss, may also decrease drinking
2013-06-14
ELSE PRESS RELEASES FROM THIS DATE:
Chronic drinking + exposure to particulate matter dramatically decreases lung function
2013-06-14
Contact: Stephania A. Cormier
scorm1@lsuhsc.edu
504-568-2810
Louisiana State University Health Sciences Center
Contact: George Leikauf
gleikauf@pitt.edu
412-383-5305
University of Pittsburgh
Alcoholism: Clinical & Experimental Research
Chronic drinking + exposure to particulate matter dramatically decreases lung function
Alveolar macrophage (AM) function plays a critical role in protecting the lungs by removing particulates.
Chronic drinking causes persistent oxidative stress in the lungs, leading to impaired AM function.
A new rodent study shows that ...
Fetal alcohol spectrum disorders and autism spectrum disorder share common molecular vulnerabilities
2013-06-14
Contact: Eva E. Redei
e-redei@northwestern.edu
312-908-1791
Northwestern University Feinberg School of Medicine
Contact: R. Thomas Zoeller
tzoeller@bio.umass.edu
413-545-2088
University of Massachusetts Amherst
Alcoholism: Clinical & Experimental Research
Fetal alcohol spectrum disorders and autism spectrum disorder share common molecular vulnerabilities
Both Fetal Alcohol Spectrum Disorders and Autism Spectrum Disorder are neurodevelopmental in origin.
A new rodent study has found that these disorders share common molecular vulnerabilities.
Findings ...
Certain environmental factors impact alcohol problems more for European than African-American women
2013-06-14
Contact: Carolyn E. Sartor
carolyn.sartor@yale.edu
203-932-5711 ext. 3894
Yale University School of Medicine
Contact: Denise Herd
tiara@berkeley.edu
510-642-4842
University of California at Berkeley
Alcoholism: Clinical & Experimental Research
Certain environmental factors impact alcohol problems more for European than African-American women
An early age at first drink (AFD) is associated with a greater risk for subsequent alcohol use disorders.
A new study looks at the influences of genetics versus the environment on AFD and problem drinking among African ...
Researchers conclude that what causes menopause is -- wait for it -- men
2013-06-14
HAMILTON, ON, June 13, 2013 — After decades of laboring under other theories that never seemed to add up, a team led by biologist Rama Singh has concluded that what causes menopause in women is men.
Singh, an evolutionary geneticist, backed by computer models developed by colleagues Jonathan Stone and Richard Morton, has determined that menopause is actually an unintended outcome of natural selection – the result of its effects having become relaxed in older women.
Over time, human males have shown a preference for younger women in selecting mates, stacking the Darwinian ...
UCSB researchers identify the mechanisms underlying salt-mediated behaviors in fruit flies
2013-06-14
(Santa Barbara, Calif.) — Next time you see a fruit fly in your kitchen, don't swat it. That fly could have a major impact on our progress in deciphering sensory biology and animal behavior, including someday providing a better understanding of the human brain.
UC Santa Barbara researchers in the Department of Molecular, Cellular, and Developmental Biology (MCDB) and the Neuroscience Research Institute (NRI) have been studying the mechanisms underlying salt taste coding of Drosophila (fruit flies). And they have made some rather remarkable discoveries. Their findings ...
Study shows how diving mammals evolved underwater endurance
2013-06-14
Scientists at the University of Liverpool have shed new light on how diving mammals, such as the sperm whale, have evolved to survive for long periods underwater without breathing.
The team identified a distinctive molecular signature of the oxygen-binding protein myoglobin in the sperm whale and other diving mammals, which allowed them to trace the evolution of the muscle oxygen stores in more than 100 mammalian species, including their fossil ancestors.
Myoglobin, which gives meat its red colour, is present in high concentrations in elite mammalian divers, so high ...
Be gone, bacteria
2013-06-14
Staph infections in hospitals are a serious concern, so much so that the term Methicillin-resistant Staphylococcus aureus (MRSA) is as commonly known as MRI. Far less known is that in many of these cases, patients are infecting themselves.
In heart surgeries and knee and joint-replacement procedures, up to 85 percent of staph infections after surgery come from patients' own bacteria, according to a 2002 study in the New England Journal of Medicine.
Despite the threat that staph bacteria pose to patients, there is no uniformly accepted procedure to reduce surgical-site ...
Could novel drug target autism and fetal alcohol disorder?
2013-06-14
CHICAGO --- In a surprising new finding, a Northwestern Medicine® study has found a common molecular vulnerability in autism and fetal alcohol spectrum disorder. Both disorders have symptoms of social impairment and originate during brain development in utero.
This the first research to explore a common mechanism for these disorders and link their molecular vulnerabilities.
The study found male offspring of rat mothers who were given alcohol during pregnancy have social impairment and altered levels of autism-related genes found in humans. Female offspring were ...
Unraveling the genetic mystery of medieval leprosy
2013-06-14
Why was there a sudden drop in the incidence of leprosy at the end of the Middle Ages? To answer this question, biologists and archeologists reconstructed the genomes of medieval strains of the pathogen responsible for the disease, which they exhumed from centuries old human graves. Their results, published in the journal Science, shed light on this obscure historical period and introduce new methods for understanding epidemics.
In Medieval Europe, leprosy was a common disease. The specter of the leper remains firmly entrenched in our collective memory: a person wrapped ...
Frontiers news briefs: June 13
2013-06-14
Frontiers in Microbiology
Insights into fungal communities in composts revealed by 454-pyrosequencing: Implications for human health and safety
Composting is a process for converting waste into materials beneficial for plant growth through the action of microbes, especially of fungi which can break down large molecules. But fungi involved in composting are not always harmless. Vidya De Gannes and colleagues show that composts can contain more fungi that are potentially harmful to humans than was previously realized. Using intensive DNA-sequencing to analyze fungal ...